Dr Thomas Althaus
Contact information
Research groups
Colleges
Thomas Althaus
MD, MSc, DPhil
Infectious disease specialist
- Principal Investigator
- Clinical Trial Manager
- Medical Doctor
Economics & Implementation Group (EIRG)
I'm an infectious disease specialist, with extensive experience in the design and management of clinical trials in resource-poor settings.
My focus is on the diagnosis and therapeutic strategies of malarial and non-malarial pathogens causing fever. I recently evaluated a point-of-care test (POCT) using C-reactive protein (CRP), to reduce antibiotic prescription among febrile children and adults attending the first lines of care, both in Southeast Asia and sub-Saharan Africa.
The global objective is to alleviate the burden of antimicrobial resistance (AMR), through better management of febrile patients.
These evaluations rely on a variety of approaches ranging from economic and epidemiological modelling through laboratory investigations to clinical trials and qualitative research.
Our ultimate aim is to provide policymakers with pragmatic and context-specific assessments of the impact of new interventions if implemented in routine care.
Key publications
-
Journal article
Lubell Y. and Althaus T., (2017), The Lancet Infectious Diseases, 17, 369 - 370
-
Journal article
Althaus T. et al, (2019), The Lancet Global Health, 7, e119 - e131
-
Journal article
Wangrangsimakul T. et al, (2018), PLOS Neglected Tropical Diseases, 12, e0006477 - e0006477
-
Journal article
Lubell Y. et al, (2015), BMC Infectious Diseases, 15
-
Journal article
Haenssgen MJ. et al, (2019), Trials, 20
Recent publications
-
Journal article
Haenssgen MJ. et al, (2020), BMJ global health, 5
-
Journal article
Althaus T. et al, (2020), International Journal of Infectious Diseases, 96, 334 - 342
-
Journal article
Althaus T. et al, (2020), Tropical Medicine & International Health, 25, 291 - 300
-
Journal article
Greer R. et al, (2020), The American Journal of Tropical Medicine and Hygiene, 102, 377 - 383
-
Journal article
Haenssgen MJ. et al, (2019), Trials, 20